ALMR · Alamar Biosciences, Inc. · Executive Compensation
Market Cap
$1.94B
Shares
69.39M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Ragusa | Class I Director | Appointed | 2026-09-01 |
Key facts
CIK
2104204
CUSIP
010911105
13F (30d)
59 filings
59 filers
Visit website
Investor relations